EVALUATION OF THE GEN-PROBE PACE 2 AND THE MICROTRAK ENZYME-IMMUNOASSAY FOR DIAGNOSIS OF CHLAMYDIA-TRACHOMATIS IN UROGENITAL SAMPLES

被引:14
作者
STARY, A [1 ]
TEODOROWICZ, L [1 ]
HORTINGMULLER, I [1 ]
NERAD, S [1 ]
STORCH, M [1 ]
机构
[1] OUTPATIENTS CTR INFECT VENERODERMATOL DIS,VIENNA,AUSTRIA
关键词
D O I
10.1097/00007435-199401000-00006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background and Objectives: The aim of the study was to investigate the value of the Gen-Probe PACE 2 assay for routine diagnosis of Chlamydia trachomatis in genital specimens of symptomatic and asymptomatic men and women patients. Study Design: Samples were collected from 90 men and 299 women patients and tested by using the Gen-Probe assay and the EIA MicroTrak. Discrepant results were further analyzed by immunofluorescence, a second run of the Gen-Probe assay, and a probe competition assay (PCA) to establish the number of true positive and negative outcomes based on the two tests used. Results: The overall prevalence of C. trachomatis was 8.5% in all patients tested (women: 3.7%, men: 13.3%) with an overall agreement of 95.4% between the two diagnostic methods. Of the 18 discordant results, 12 (67%) were considered to be false positive in the Gen-Probe assay and 3 (16%) false positive in the EIA. Two (11%) positive results were missed in the Gen-Probe assay and 1 (6%) in the EIA, all observed in female specimens. The sensitivities and specificities of the EIA were 91.7% and 100% for men and 100% and 99% for women, and for the Gen-Probe assay were 83.3% and 100% for men and 100% and 95.8% for women, respectively, when compared with true positive and true negative results. Although the predictive value for all positive results (PVP) was 88% for the EIA and 78.2% for the Gen-Probe assay, it was only 47.8% for positive female samples when using the Gen-Probe assay. Conclusion: The Gen-Probe assay revealed a sensitivity comparable with the EIA. The accuracy of test results provided by a single Gen-Probe assay was considerably lower than by Micro-Trak reducing the utility of PACE 2 as a diagnostic technique for Chlamydia diagnosis. Due to the high rate of false-positive samples in the Gen-Probe assay, positive results with a low value of relative light units have to be further analyzed by confirmation procedures.
引用
收藏
页码:26 / 30
页数:5
相关论文
共 23 条
[11]  
MERCER LJ, 1990, OBSTET GYNECOL, V76, P114
[12]   CONFIRMATORY ASSAY INCREASES SPECIFICITY OF THE CHLAMYDIAZYME TEST FOR CHLAMYDIA-TRACHOMATIS INFECTION OF THE CERVIX [J].
MONCADA, J ;
SCHACHTER, J ;
BOLAN, G ;
ENGELMAN, J ;
HOWARD, L ;
MUSHAHWAR, I ;
RIDGWAY, G ;
MUMTAZ, G ;
STAMM, W ;
CLARK, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (08) :1770-1773
[13]   USE OF POLYMERASE CHAIN-REACTION FOR DETECTION OF CHLAMYDIA-TRACHOMATIS [J].
OSTERGAARD, L ;
BIRKELUND, S ;
CHRISTIANSEN, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (06) :1254-1260
[14]   COMPARISON OF GEN-PROBE DNA PROBE TEST AND CULTURE FOR THE DETECTION OF NEISSERIA-GONORRHOEAE IN ENDOCERVICAL SPECIMENS [J].
PANKE, ES ;
YANG, LI ;
LEIST, PA ;
MAGEVNEY, P ;
FRY, RJ ;
LEE, RF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (05) :883-888
[15]   CURRENT PROBLEMS IN MICROBIOLOGY .1. CHLAMYDIAL INFECTIONS - WHICH LABORATORY TEST [J].
RIDGWAY, GL ;
TAYLORROBINSON, D .
JOURNAL OF CLINICAL PATHOLOGY, 1991, 44 (01) :1-5
[16]  
STARY A, 1985, GENITOURIN MED, V61, P258
[17]   COMPARISON OF DNA-PROBE TEST AND CULTURE FOR THE DETECTION OF NEISSERIA-GONORRHOEAE IN GENITAL SAMPLES [J].
STARY, A ;
KOPP, W ;
ZAHEL, B ;
NERAD, S ;
TEODOROWICZ, L ;
HORTINGMULLER, I .
SEXUALLY TRANSMITTED DISEASES, 1993, 20 (05) :243-247
[18]   MEDICAL HEALTH-CARE FOR VIENNESE PROSTITUTES [J].
STARY, A ;
KOPP, W ;
SOLTZSZOTS, J .
SEXUALLY TRANSMITTED DISEASES, 1991, 18 (03) :159-165
[19]   CULTURE-INDEPENDENT DIAGNOSIS OF CHLAMYDIA-TRACHOMATIS USING MONOCLONAL-ANTIBODIES [J].
TAM, MR ;
STAMM, WE ;
HANDSFIELD, HH ;
STEPHENS, R ;
KUO, CC ;
HOLMES, KK ;
DITZENBERGER, K ;
KRIEGER, M ;
NOWINSKI, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (18) :1146-1150
[20]  
TAYLORROBINSON D, 1991, GENITOURIN MED, V67, P256